Standard InChI: InChI=1S/C44H26O12/c45-37-23-9-1-5-13-27(23)53-41(49)33(37)31(34-38(46)24-10-2-6-14-28(24)54-42(34)50)21-17-19-22(20-18-21)32(35-39(47)25-11-3-7-15-29(25)55-43(35)51)36-40(48)26-12-4-8-16-30(26)56-44(36)52/h1-20,31-32,49-52H
Standard InChI Key: GSKXJQZBERQLFV-UHFFFAOYSA-N
Associated Targets(Human)
Homo sapiens 32628 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
DNA topoisomerase I 7553 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
CCRF-CEM 65223 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Quinone reductase 1 1746 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Human immunodeficiency virus type 1 integrase 9041 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Human immunodeficiency virus type 1 protease 9113 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Human immunodeficiency virus type 1 reverse transcriptase 18245 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Human immunodeficiency virus type 2 integrase 9 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Feline immunodeficiency virus 139 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Simian immunodeficiency virus 338 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Mus musculus 284745 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Staphylococcus aureus 210822 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 746.68
Molecular Weight (Monoisotopic): 746.1424
AlogP: 7.30
#Rotatable Bonds: 6
Polar Surface Area: 201.76
Molecular Species: ACID
HBA: 12
HBD: 4
#RO5 Violations: 3
HBA (Lipinski): 12
HBD (Lipinski): 4
#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.72
CX Basic pKa:
CX LogP: 7.86
CX LogD: -0.11
Aromatic Rings: 9
Heavy Atoms: 56
QED Weighted: 0.13
Np Likeness Score: 0.03
References
1.Wang S, Milne GW, Yan X, Posey IJ, Nicklaus MC, Graham L, Rice WG.. (1996) Discovery of novel, non-peptide HIV-1 protease inhibitors by pharmacophore searching., 39 (10):[PMID:8642563][10.1021/jm950874+]
2.Mazumder A, Wang S, Neamati N, Nicklaus M, Sunder S, Chen J, Milne GW, Rice WG, Burke TR, Pommier Y.. (1996) Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease., 39 (13):[PMID:8691444][10.1021/jm960074e]
3.Zhao H, Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Milne GW, Pommier Y, Burke TR.. (1997) Coumarin-based inhibitors of HIV integrase., 40 (2):[PMID:9003523][10.1021/jm960450v]
4.Hong H, Neamati N, Wang S, Nicklaus MC, Mazumder A, Zhao H, Burke TR, Pommier Y, Milne GW.. (1997) Discovery of HIV-1 integrase inhibitors by pharmacophore searching., 40 (6):[PMID:9083481][10.1021/jm960754h]
5.Nolan KA, Zhao H, Faulder PF, Frenkel AD, Timson DJ, Siegel D, Ross D, Burke TR, Stratford IJ, Bryce RA.. (2007) Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity., 50 (25):[PMID:17999461][10.1021/jm070472p]
6.Hamdi N, Puerta MC, Valerga P.. (2008) Synthesis, structure, antimicrobial and antioxidant investigations of dicoumarol and related compounds., 43 (11):[PMID:18485537][10.1016/j.ejmech.2008.03.038]